TN2013000025A1 - Composition pharmaceutique a liberation prolongee de trimetazidine - Google Patents

Composition pharmaceutique a liberation prolongee de trimetazidine

Info

Publication number
TN2013000025A1
TN2013000025A1 TNP2013000025A TN2013000025A TN2013000025A1 TN 2013000025 A1 TN2013000025 A1 TN 2013000025A1 TN P2013000025 A TNP2013000025 A TN P2013000025A TN 2013000025 A TN2013000025 A TN 2013000025A TN 2013000025 A1 TN2013000025 A1 TN 2013000025A1
Authority
TN
Tunisia
Prior art keywords
trimetazidine
pharmaceutical composition
prolonged release
retarder
outer layer
Prior art date
Application number
TNP2013000025A
Other languages
English (en)
Inventor
Genty Patrick
Hermelin Christophe
Pean Jean-Manuel
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Priority to TNP2013000025A priority Critical patent/TN2013000025A1/fr
Publication of TN2013000025A1 publication Critical patent/TN2013000025A1/fr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Composition à libération prolongée de trimétazidine dans laquelle la phase interne comprend de la trimétazidine et la couche externe comprend un retardant et un anti-agglomérant.
TNP2013000025A 2013-01-28 2013-01-28 Composition pharmaceutique a liberation prolongee de trimetazidine TN2013000025A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TNP2013000025A TN2013000025A1 (fr) 2013-01-28 2013-01-28 Composition pharmaceutique a liberation prolongee de trimetazidine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TNP2013000025A TN2013000025A1 (fr) 2013-01-28 2013-01-28 Composition pharmaceutique a liberation prolongee de trimetazidine

Publications (1)

Publication Number Publication Date
TN2013000025A1 true TN2013000025A1 (fr) 2014-06-25

Family

ID=54359521

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000025A TN2013000025A1 (fr) 2013-01-28 2013-01-28 Composition pharmaceutique a liberation prolongee de trimetazidine

Country Status (1)

Country Link
TN (1) TN2013000025A1 (fr)

Similar Documents

Publication Publication Date Title
EP3452003A4 (fr) Forme pharmaceutique à libération contrôlée
CL2015000295A1 (es) Compuestos derivados de alquilpirimidina; composicion farmaceutica que los comprende; uso para el tratamiento de infecciones víricas y otras enfermedades.
BR112016000489A2 (pt) composto, composição farmacêutica que o compreende, uso da composição e métodos para fabricar compostos
EP3454899C0 (fr) Composition pharmaceutique
EP2953618A4 (fr) Formulations pharmaceutiques inviolables
HUE036128T2 (hu) Hasznos atkák kibocsátására alkalmas rendszer és ennek alkalmazása
DK3386575T3 (da) Enkeltdosisinhalator til engangsbrug til pulveriserede medikamenter
EP2990038A4 (fr) Composition pharmaceutique solide
UY34786A (es) Procedimiento para la fabricación de una forma farmacéutica que comprende nifedipino y candesartan cilexetilo
EP2623096A3 (fr) Composition pharmaceutique a liberation prolongée de trimetazidine
EP2987489A4 (fr) Formulation de médicament à libération contrôlée
ZA201508249B (en) A pharmaceutical composition containing budesonide and formoterol.
EP2968179A4 (fr) Formes galéniques pharmaceutiques à libération contrôlée
EP3187187A4 (fr) Adsorbant pour administration par voie orale, agent thérapeutique pour maladies rénales et agent thérapeutique pour maladies hépatiques
LT3601277T (lt) Farmacinė vaisto forma
TN2013000025A1 (fr) Composition pharmaceutique a liberation prolongee de trimetazidine
LU92526B1 (fr) Medicament de combinaison comprenant de la phenylephrine et du paracetamol
PT3357492T (pt) Comprimido com múltiplas camadas para a administração de magnésio
BR112014026040A2 (pt) tablete de liberação sustentada que contém levodropropizina e método para preparar o mesmo
EP2961389A4 (fr) Comprimé à matrice de cire de citrate de potassium à libération prolongée à haute dose
EP2628488A4 (fr) Composition pharmaceutique à libération entretenue
DK2908836T3 (da) Farmaceutisk formulering indeholdende curcuma
HRP20181919T1 (hr) Pedijatrijska tableta za žvakanje koja sadrži antivirusni agent i postupak pripreme iste
EP2575820A4 (fr) Forme pharmaceutique à libération prolongée comprenant de la quétiapine
DK3071267T3 (da) Lægemiddeladministrationsanordning med ensrettet kobling